Abatacept for Steroid-Refractory Chronic Graft-vs-Host Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease
Blood 2023 Mar 02;[EPub Ahead of Print], AG Koshy, HT Kim, J Liegel, JE Arnason, VT Ho, JH Antin, R Joyce, CS Cutler, M Gooptu, S Nikiforow, EK Logan, P Elavalakanar, M Narcis, D Stroopinsky, ZM Avigan, L Boussi, SL Stephenson, H El Banna, P Bindal, G Cheloni, DE Avigan, RJ Soiffer, J RosenblattFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.